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Abstract.  Two putative receptors for fibroblast growth 
factor (FGF) of ~150 and 200 kD were identified in 
membrane preparations  from chick embryos. Specific 
binding (femtomoles/milligram) of ~25I-aFGF to whole 
chick embryonic membranes was relatively constant 
from day 2  to 7, then decreased fivefold between days 
7 and  13.  Day-19 chick embryos retained  ~25I-aFGF 
binding  at low levels to brain,  eye, and liver tissues 
but not to skeletal muscle or cardiac tissues. The 200- 
kD FGF receptor began to decline between day 4.5 
and 7 and was barely detectable by day 9,  whereas the 
150-kD FGF receptor began to decline by day 7 but 
was still  detectable in day-9 embryonic membranes.  It 
is not known whether the two FGF-binding proteins 
represent altered forms of one polypeptide, but it is 
clear that their levels undergo differential changes dur- 
ing development.  Because endogenous chick FGF may 
remain bound to FGF receptor in membrane prepara- 
tions,  membranes were treated with acidic (pH 4.0) 
buffers to release bound FGF;  such treatment  did not 
affect ~25I-aFGF binding and moderately increased the 
number of binding  sites in day-7 and -19 embryos. 
Consequently, the observed loss of high affinity 
m2SI-aFGF binding  sites and FGF-binding polypeptides 
most likely represents a loss of FGF receptor protein. 
These experiments provide in vivo evidence to support 
the hypothesis that regulation of FGF receptor levels 
may function as a mechanism for controlling FGF- 
dependent processes during embryonic development. 
ROWTH factors mediate crucial regulatory events gov- 
erning  embryonic development.  Acidic  and  basic 
fibroblast growth factors (aFGF and bFGF, respec- 
tively) t have been shown to induce mesoderm tissue in Xeno- 
pus animal  region  explants  (Slack  et al.,  1987; Kimelman 
and Kirschner,  1987) and repress skeletal muscle differentia- 
tion in human,  mouse, and chick skeletal muscle myoblast 
cultures (Linkhart  et al.,  1981; Clegg et al.,  1987; Seed and 
Hauschka, 1988; Snow, M. H., and S. D. Hauschka, unpub- 
lished observations). Fibroblast growth factor (FGF) effects 
in  vivo  include  modulation  of mesoderm  and  endoderm 
differentiation  in rat embryos (Liu and Nicoll, 1988) and in- 
duction of angiogenesis (reviewed in Baird et al., 1986; Folk- 
man  and  Klagsbrun,  1987; Gospodarowicz et al.,  1987). 
FGF-like polypeptides have been identified  in unfertilized 
eggs and embryos from Xenopus (Kimelman  et al.,  1988) 
and chick (Seed et al.,  1988). FGF has also been identified 
in the chick limb bud (Seed et al.,  1988;  Muniam et al., 
1988) and brain (Risau, 1986; Risau et al., 1988; Mascarelli 
et al., 1987) and has been purified from adult chick skeletal 
muscle (Kardami et al.,  1985). Immunolocalization  studies 
have shown that bFGF is present in the developing cardiac 
1. Abbreviations  used in this paper:  aFGE acidic fibroblast growth factor; 
bFGE basic fibroblast growth factor; FGF, fibroblast growth factor; PBSMG, 
PBS containing 2 mM MgCI2 and 0.2% bovine gamma globulin. 
and somite regions  of chick embryos as early as stages  12 
and  19, respectively  (Joseph-Silverstein  et al.,  1989).  The 
immunostaining  persists  in later  heart muscle and in limb 
myoblasts and myotubes through day 12 (Joseph-Silverstein 
et al.,  1989). Immunopositive  bFGF staining has also been 
observed in adult chick muscle fiber basdment  lamina,  but 
not on the muscle fibers (DiMario et al.,  1989). 
The FGF-dependent induction  of mesoderm in Xenopus 
animal  pole explants  (Slack et al.,  1987; Kimelman;and 
Kirschner,  1987) and repression of terminal  differentiation 
in chick skeletal muscle cultures (Seed and Hauschka, 1988) 
suggests the presence of FGF receptors in these tissues. FGF 
receptors have been identified in many cultured primary cells 
and cell lines (for reviews see Folkman and Klagsbrun,  1987; 
Gospodarowicz et al.,  1987); two studies of FGF receptors 
in  vivo have reported their  presence in membranes  from 
adult bovine brain (Courty et al., 1988) and murine embryos 
(Olwin and Hauschka,  1989). 
The present studies were undertaken to identify embryonic 
chick FGF receptors and to quantitate  the levels  of FGF 
receptor during chick development.  Previous experiments 
had demonstrated  that  FGF receptors are present at much 
greater levels in embryonic vs. adult murine tissues (Olwin 
and Hauschka, 1989). Since chick embryos had been shown 
to contain high levels of FGF (Seed et al., 1988), we antici- 
paled that embryonic chick tissues would exhibit detectable 
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growth factor receptors during skeletal muscle differentia- 
tion  in  culture  (Lim  and  Hauschka,  1984;  Clegg  and 
Hauschka, 1987; Olwin and Hauschka, 1988) suggested that 
FGF receptor levels were likely to undergo changes during 
chick embryogenesis.  The data presented in this report pro- 
vide preliminary confirmation of these predictions. 
Materials and Methods 
Embryonic chick tissue was obtained from White Leghorn eggs incubated 
in a forced-draft incubator. Na~251 and [3H]thymidine were purchased from 
New England Nuclear (Boston, MA).  Disuccinimidyl suberate was pur- 
chased from Pierce Chemical Co.  (Rockford,  IL) and HVLP Durapore 
membranes were purchased  from  Millipore Continental Water  Systems 
(Bedford, MA). aFGF and bFGF were purified from bovine brain as previ- 
ously described (Olwin and  Hauschka,  1986, 1989)  by  heparin-agarose 
affinity  chromatography  and  ion  exchange chromatography  on  mono-S 
columns (Pharmacia Fine Chemicals, Piscataway,  N  J). Purity of aFGF and 
bFGF preparations was >95 % as judged by reverse-phase HPLC analysis 
on a Vydac C4 column and by silver staining of FGF preparations analyzed 
by SDS-PAGE (Laemmli,  1970). 
lodination of  aFGF  and bFGF 
A  procedure was developed using chloramine T that allows iodination of 
aFGF and bFGF to high specific activity with full  retention of biological 
activity and recoveries of FGF between 30 and 60%.  To 0.5 #g of either 
aFGF or bFGE 10/~l of 0.5 M sodium phosphate, pH 7.0, 15/~1 of 0.45 M 
chloramine T, and 0.5 mCi of Nal25I were added for a final volume of 50 
#l. The reaction was allowed to proceed for 2 min, and 50 #1 of  0.025 M DTT 
was added and allowed to react for 3 rain. The 125I-FGF was then diluted 
with 100 #1 of 20 mM Hepes, pH 7.4,  and 0.2% bovine gamma globulin 
and purified on an 0.2-rot heparin-agarose column as described previously 
(Olwin and Hauschka,  1986).  Addition of DTT increased recoveries from 
heparin-agarose columns by 1.5- to 2-fold (Kan et al., 1988).  12~I-FGF  was 
then diluted to 5  x  105 cpm/#l and stored at 4°C. The labeled proteins were 
stable for at least 1 mo, and specific activities, determined from MMI4 cell 
growth assays (Olwin and Hauschka,  1986),  ranged from 3,000  to 7,000 
dpm/fmol. 
Embryonic Membrane Preparation 
Chick developmental stages were determined according to Hamburger and 
Hamilton (1951). Data were obtained from chick embryos at stages 15,  18, 
20,  25, 29,  and 31, which correspond to embryonic days 2, 3, 3.5, 4.5, 6, 
and 7, respectively. Older chick embryos were not staged. In the text, em- 
bryos will be identified by their age in days. Unless otherwise described, 
embryonic chick cell membranes were prepared by dissection of embryos 
from the surrounding extraembryonic membranes and ~lk,  washing the 
embryos three times with PBS (50 mM sodium phosphate, pH 7.4, and 100 
mM NaCI), adding 2 vol of homogenization buffer (20 mM Hepes, pH 7.4, 
0.25 M sucrose, 1 mM EDTA, 1 mM EGTA, 20 kallikrein units aprotinin/ 
ml,  1 #g/ml leupeptin, 1 mM PMSF), and homogenizing three times for 
30-s bursts at 10,000 rpm with a tissue homogenizer (Tekmar Co., Cincin- 
nati, OH). The homogenate was then centrifuged at  15,000 g  for 45 rain, 
resuspended in 2 vol of  homogenization buffer by homogenization, and cen- 
trifuged at  100,000 g  for 30 rain. The pellet was resuspended in 2  vol of 
homogenization buffer and centrifuged twice more as described above. Fi- 
nal protein concentrations were adjusted to 5-10 mg/ml, and crude mem- 
branes were immediately frozen in liquid N2 and stored at -70°C. No loss 
in receptor affinity  or number was observed upon freezing and storage at 
-70°C for 2  wk. 
Membrane FGF Receptor Assay 
Particulate FGF receptor was assayed as follows. Membrane protein (20 ug) 
in PBS containing 2 mM MgCI2 and 0.2% bovine gamma globulin (PBS- 
MG) was added to tubes containing 12SI-aFGF  and 125I-bFGF with or with- 
out a  100-fold molar excess of unlabeled aFGF or bFGF and PBSMG for 
a final volume ofO.1 ml. After 30 min at 22°C, the assays were terminated 
by dilution with 2.5 ml PBSMG and immediate application under vacuum 
to Durapore HVLP membrane filters (25 mm, 0.45 #m; Millipore Contin- 
ental Water Systems) presoaked in 5 % bovine gamma globulin. The tubes 
were rinsed twice with 2.5 ml PBSMG. The filters were then removed, and 
the 125I-aFGF or  12SI-bFGF bound to the particulate membrane fraction 
was determined by counting in a gamma counter. Less than 0.2 % of  the total 
applied  ~25I counts per minute bound to filters in the absence of mem- 
branes. 
Cross-linking ~2JI-aFGF  Membrane Receptors 
Cross-linking of 125I-aFGF to particulate FGF receptors was accomplished 
by performing a binding assay with the following modifications and addi- 
tions. Membranes (50/~g per assay) were diluted lO~fold with PBS after the 
30-min incubation for I~I-aFGF binding, centrifuged 5  min at  13,000 g, 
and washed once with PBS. The pellet was then resuspended in 1 ml of PBS 
containing 0.15 mM disuccinimidyl suberate (diluted from an 0.05 M stock 
in DMSO) and incubated at 22°C for 15 rain followed by addition of 1 #1 
of  1  M  unbuffered Tris  base.  The  reaction was centrifuged as  above, 
resuspended in 25 ~,l homogenization buffer containing 1% Triton X-100, 
and incubated on ice for 15 min; insoluble materials were removed by cen- 
trifugation as above. The supernatant was diluted 1:1 in H20, SDS-PAGE 
sample buffer was added, and the samples were boiled for 2 rain. Samples 
were analyzed by SDS-PAGE in 7.5 % gels and subjected to autoradiography 
at  -70°C with a Cronex Lightning Plus intensifying ~reen (DuPont Co., 
Wilmington, DE).  Protein concentrations were determined according to 
Bradford (1976) using Pentex BSA (Miles Scientific Di~,., Naperville, IL) 
as a standard. 
Results 
Identification and Characterization of Chick FGF 
Binding Sites 
Chick  FGF  receptors  were  detected by  incubating  chick 
membranes  with  ~2SI-aFGF and  12q-bFGE Both  labeled 
ligands  exhibit  high  affinity, specific  binding  to chick em- 
bryonic membranes (Fig.  1). Isolation of plasma membranes 
by  discontinuous  gradient  centrifugation  yielded  similar 
results  to those observed in Fig.  1, with a 40% recovery of 
~25I-aFGF binding  sites  (our  unpublished  data).  Because 
60%  losses of ~25I-aFGF binding  occur upon  isolation  of 
plasma  membranes,  unfractionated  membrane preparations 
were used for subsequent experiments.  ~25I-aFGF binding 
exhibits much less low affinity and nonspecific binding than 
does mI-bFGF (Fig.  1).  The results  from Fig.  1 suggested 
that  20 #g of membrane protein was an optimum for the 
binding analyses. In addition,  these data demonstrate  satura- 
tion of ~25I-aFGF and ~2SI-bFGF  by FGF-binding  proteins  in 
the membrane preparations.  The high levels of"nonspecific" 
binding of bFGF are not due to contaminants  in the bovine 
bFGF  preparation  since  recombinant  human  t2~I-bFGF 
yields essentially  identical  results  (our unpublished  data). 
Attempts  to reduce nonspecific  and  low affinity  ~2~I-bFGF 
binding by washing membranes with  1-2 M NaCI reduced 
both the total and nonspecific  binding  by 5- to lO-fold (our 
unpublished  data).  To avoid potential  artifacts  due to high 
levels  of ~25I-bFGF nonspecific  binding,  the  remainder  of 
these  studies  examine  only  ~2~I-aFGF binding.  Although 
aFGF and bFGF compete for the same high affinity receptors 
in a variety  of vertebrate  cell lines  (Olwin and  Hauschka, 
1986,  1989;  Neufeld and  Gospodarowicz,  1986),  distinct 
bFGF receptors or receptors specific for chick FGF present 
in the chick embryo might not be recognized  by ~2SI-aFGF; 
if so, the total FGF receptor number may be underestimated. 
Dissection of day-7 chick embryos revealed nearly equiva- 
lent specific binding of ~25I-aFGF in embryonic head, body, 
and limbs (our unpublished  data).  Since equivalent  specific 
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Figure 1. Binding of bovine ~25I-aFGF  and 125I-bFGF  to embryonic 
membranes from day-7 chick embryos. (?bp) Increasing amounts of 
crude chick membranes were incubated with 200 pM ~25I-aFGF  in 
the absence  (0) and presence  (e) of a  100-fold molar excess of 
aFGF and processed as described in Materials and Methods. Data 
are plotted as the mean and standard deviation of background sub- 
tracted  t25I counts  per minute.  Specifically bound  ~25I-aFGF (o) 
was obtained by subtraction of ~25I-aFGF  counts per minute bound 
in the presence of excess aFGF from the total ~25I-aFGF  counts per 
minute bound.  (Bottom) Increasing amounts of crude chick mem- 
branes were incubated with 200 pM ~25I-bFGF  in the absence (0) 
and presence (o) of a lO0-fold molar excess of bFGE Data were 
plotted  and  specifically bound  ~25I-bFGF (n) was determined  as 
described  above. 
binding of '2SI-aFGF was observed in these three regions, 
whole chick embryos were used for the initial  analysis of 
FGF receptor expression during early stages of chick devel- 
opment.  A  survey of individual  tissues  was  examined  in 
chick embryos greater than 7-d-old since preparation of whole 
chick embryo membranes was not feasible. 
Unlabeled aFGF and embryonic chick FGF (Seed et al., 
1988) compete for specific binding of L2q-aFGF, suggesting 
these factors bind to common binding sites (Fig. 2). Compe- 
tition  of bound  ~2SI-aFGF was  expected  to  require  more 
chick  FGF  than  bovine  aFGF  since  chick  FGF  was  not 
purified to homogeneity (Seed et al.,  1988).  Because chick 
FGF and bovine aFGF both displaced 82 % of the total bound 
'25I-aFGF, bovine t25I-aFGF appears to interact with at least 
one class of chick FGF receptors. Moreover, a purified 150- 
kD chick FGF receptor binds bovine aFGF, human recom- 
binant bFGF,  and bovine bFGF with high affinity (Burrus 
and Olwin,  1989).  Consequently,  it seemed reasonable to 
use bovine ~25I-aFGF for further quantitation and identifica- 
tion of chick FGF receptors during chick embryogenesis. 
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Figure 2. Competition of bound bovine 125I-aFGF  by bovine aFGF 
and chick FGE Crude chick membranes (20 #g) from day-7 em- 
bryos were incubated with 75 pM I'I-aFGF in the presence of in- 
creasing  concentrations  of aFGF (0) or partially  purified chick 
FGF  (o)  and  specifically  bound  t2SI-aFGF determined  as  de- 
scribed in Materials and Methods. Data were plotted as the mean 
and standard deviation of specifically bound  ~2~I-aFGF  as a func- 
tion of the log of the total molar concentration of unlabeled FGE 
Chick  FGF from day-7 embryos was partially  purified  through 
heparin-agarose affinity columns as previously described (Seed et 
al., 1988). The protein concentration for chick FGF is reported as 
the log of the total molar FGF concentration. 
Levels of FGF Receptor in Chick Embryos 
Embryonic chick membranes were prepared and analyzed 
for  FGF  receptor  levels  by  determination  of specifically 
bound  ~25I-aFGE From day 2, the earliest stage measured, 
to day 7,  specific binding of ~25I-aFGF remained relatively 
constant  (Fig.  3  a),  while  in  day-7-13  whole  embryos, 
specific binding of '25I-aFGF decreased fourfold.  In entire 
limbs and skeletal muscle tissue, FGF receptors exhibited a 
progressive decline from day 7  to 22  (1  d  after hatching), 
when receptors were undetectable (Fig. 3 b). FGF receptors 
in heart tissue were also undetectable by day 19, whereas low 
levels of FGF receptor were still detectable in brain, eye, and 
liver (Fig.  3 a). 
Putative  FGF  receptor  polypeptides  were  identified  by 
cross-linking  '2~I-aFGF to  embryonic membrane prepara- 
tions.  Separation  of the  cross-linked  complexes by  SDS- 
PAGE  and  subsequent  autoradiographic  analysis  distin- 
guished two  ~25I-aFGF-FGF receptor complexes migrating 
at •170  and 215 kD (Fig. 4). The complex migrating at 170 
kD is similar to migration of ~25I-aFGF-FGF receptor com- 
plexes  from  mammalian  cells  in  culture  (Olwin  and 
Hauschka,  1986,  1988,  1989).  Assuming  stoichiometric 
binding,  subtraction of the molecular mass for aFGF from 
the two complexes yielded values of "~ 200 and  150 kD for 
the FGF receptors. Whether the larger receptor, which has 
not been previously characterized, is distinct from or related 
to the smaller receptor is currently unknown.  In agreement 
with the binding data presented in Fig. 3, the amounts of both 
cross-linked complexes appear relatively constant from day 
2 to 7 and begin to decline between days 7 and 9 (Fig. 4). 
Disappearance of the 200-kD receptor appears to begin be- 
fore the decline of the 150-kD receptor, suggesting these may 
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Figure 3. FGF receptor levels in embryonic chick. (a) FGF receptor levels in whole chick embryo from day 2 to 13 and  in brain, eye, 
heart, and liver from day 17 and 19 embryonic membranes.  (b) FGF receptor levels in limbs (L) from day 6 to 9 and in skeletal muscle 
(skm) from day 13 to 22 (1 day after hatching).  FGF receptor levels were determined  by specific binding of ~2SI-aFGF  to staged embryos. 
Membrane assays contained  250 pM ~25I-aFGF (saturating)  +  a lO0-fold molar excess of unlabeled  aFGE Specific binding  of ~25I-aFGF 
reported  as femtomoles  J25I-aFGF  bound per milligram  membrane protein  is equivalent  to femtomoles  FGF receptor per milligram  pro- 
tein, assuming stoichiometric  interaction  of ~2SI-aFGF  with FGF receptor.  Numbers in parentheses  refer to the developmental  stage as de- 
termined according to Hamburger and Hamilton (195t). For each data point at least two independent  extracts were analyzed in two separate 
assays, each performed in triplicate,  except for day-6 limb,  where one extract  was analyzed. For day-2-7 embryos, 20 #g of protein  was 
present  per assay. For older embryos, assays were performed with 20 #g and, when less than  10 fmol/mg bound ~25I-aFGF was detected, 
50 #g of membrane protein.  Data are plotted  as the mean and standard  deviation  of these  values. 
be  distinct,  independently  regulated  FGF  receptors.  Both 
receptor complexes appear to bind aFGF and bFGF since a 
lO0-fold molar excess of either growth factor competes for 
~25I-aFGF binding (Fig.  4). 
Comparison  of  FGF  Affinities in Early with 
Late Embryos 
The binding and cross-linking data suggest that FGF recep- 
tor levels are regulated during chick embryogenesis.  How- 
ever,  these experiments do not address whether changes in 
the number of FGF receptors  or changes in FGF  receptor 
affinity  are  responsible  for the  apparent  loss of ~2q-aFGF 
binding  and  cross-linking.  Therefore,  the  affinity  and  the 
number  of  '2q-aFGF  binding  sites  were  determined  in 
membranes from day-3.5 whole embryos and day-19 brain. 
Scatchard  analysis  of  equilibrium  binding  data  revealed 
moderate changes in the Kd for ~25I-aFGF binding to whole 
day-3.5 chick embryo membranes (70 pM) vs. day-7 (ranges 
from  100  to 232  pM)  and  day-19 embryonic brain  (•140 
pM).  Comparisons  of  Kas  between  early  and  late  em- 
bryonic stages are problematic due to the drastic overall loss 
Figure 4. Cross-linking  of 12SI-aFGF  to staged chick membranes.  Crude membrane preparations  of (50 #g) were incubated  with 250 pM 
12SI-aFGF in the absence or in the presence of a 100-fold molar excess of unlabeled  aFGF or bFGE The membranes were washed,  cross- 
linked with disuccinimidyl suberate,  and processed for automdiography as described in Materials  and Methods.  Identical amounts of mem- 
brane protein (25 #g) were loaded in each lane,  Determinations  of relative molecular weights were made from Rf values calculated  using 
Bio-Rad Laboratories (Richmond, CA) high molecular weight SDS-PAGE standards (not shown). These data are representative  of  two inde: 
pendent experiments. 
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fmol/mg for day-19 brains (the highest major tissue assayed 
at this stage).  Such comparisons do, however, suggest that 
major changes in FGF receptor K~s do not occur between 
these stages of development. 
Analysis of"Cryptic" FGF Receptors 
Apparent modulation of FGF receptor levels could also oc- 
cur due to differences in endogenous FGF levels between late 
and  early embryos.  Higher concentrations of FGF  might 
lead to residual FGF during preparations of crude membrane 
extracts and consequently mask FGF binding sites. To assess 
this possibility, membrane preparations were exposed to an 
acid treatment that previous studies  in our lab had  shown 
releases  bound  '25I-aFGF  from  intact  skeletal  muscle 
(MMI4) and Swiss 3T3 cells (Olwin, B. B., unpublished  data). 
Such treatment was therefore expected to release bound en- 
dogenous  chick  FGF  from  membrane  preparations.  Em- 
bryonic (day 7) membranes were prepared as described in 
Materials and Methods, resuspended in neutral or acidic (pH 
4.0) buffers for 30 min, centrifuged twice at  100,000 g, re- 
suspended, and tested for FGF binding. Treatment of mem- 
branes with acidic buffers modestly increased the number of 
binding sites when compared with control membranes (Table 
I).  To further substantiate  that  endogenous FGF  was  not 
released during the acidification procedure, initial superna- 
tants from neutral and acid extraction were also adjusted to 
neutral pH and assayed for the presence of FGF by the same 
competitive binding procedure described in Fig. 2. No com- 
petition by supernatants from either neutral or acidified mem- 
branes was observed (our unpublished data); this assay has 
a detection limit for unbound FGF of 3 fmol or 50 pg (Seed 
et al.,  1988). 
To ensure that a large number of '25I-aFGF binding sites 
were not masked in day-19 embryos, brain and skeletal mus- 
cle membranes were treated with acidic buffers as described 
above.  The  number  of  ~25I-aFGF binding  sites  in  acid- 
treated brain membranes was approximately two-fold greater 
Table L J251-aFGF  Binding to Treated and 
Untreated Membranes 
Age  Treatment*  Kd  Membrane protein bound 
d  pM  fmol/mg 
7  Control  232  90 
pH 4.0  269  140 
19  (brain)  Control  .u 140~  '~5~  t 
pH 4.0  160  10 
19  (skeletal  muscle)  Control  na-~  0.03+  0.06II 
pH 4.0  na§  0 
* Crude  membranes  prepared  as described  in  Materials  and  Methods  were 
treated  with an acidic buffer (pH 4.~0) to release bound endogenous FGF as 
described  in the text. 
~t The low levels of 'zSI-aFGF  binding did not allow an accurate determination 
of the Kj or numbers of binding sites. The data given represent approximate 
values. 
§ ha,  not applicable.  Saturation binding of '-'~I-aFGF  was determined  by in- 
cubating  membranes  (50  t~g) with  200  pM  '251-aFGF in  the  absence  and 
presence  of excess  unlabeled  FGF as described  in Materials  and  Methods. 
Reported values represent three  independent determinations. 
II Note that the  standard  deviation  for this  measurement  is greater  than the 
value reported and,  thus,  these data are  interpreted as indicating no specific 
binding of ~251-aFGF to skeletal muscle membranes. 
than in control brain membranes when analyzed by Scatch- 
ard  analysis  of equilibrium  binding  data,  similar  to  the 
changes observed for day-7 membranes (Table I). No specific 
binding  for  '25I-aFGF  was  observed  in  skeletal  muscle 
membranes that were acidified or untreated (Table I). Con- 
sistent with results from day-7 embryos, acid treatment of 
day-19 embryos does not reveal a  large number of binding 
sites masked by endogenous FGF.  It thus appears that the 
loss of FGF binding sites observed during chick embryogen- 
esis represents an actual loss of FGF receptor. 
Discussion 
Chick embryonic membranes exhibit high affinity, specific 
binding  to  bovine  '25I-aFGE  Because  bovine  aFGF  and 
bFGF and  chick FGF compete for the  '25I-aFGF  binding 
sites,  all may bind common receptor polypeptides. Cross- 
linking  'zSI-aFGF to embryonic membranes identified two 
putative FGF receptors, one of which appears similar in bio- 
chemical characteristics to previously identified FGF recep- 
tors present in cultured mammalian cells (~165 kD; Olwin 
and Hauschka, 1989). A second FGF receptor of ~  200 kD, 
which has not been observed in mammalian cells, was de- 
tected by cross-linking to  '25I-aFGE  Although neither the 
150-  nor 200-kD FGF-binding proteins were conclusively 
shown to be cell surface FGF receptors in this study, the 150- 
kD FGF-binding protein has been purified (Burrus and Ol- 
win,  1989).  Since the  150-kD FGF-binding protein binds 
'25I-aFGF and  '2SI-bFGF with high affinity and  is a  mem- 
brane glycoprotein present on chick embryo fibroblasts (Bur- 
rus and Olwin,  1989; Lueddecke, B. A., A. J.  Kudla, and 
B. B. Olwin, manuscript in preparation), it most likely is an 
FGF receptor. Whether the 200-kD protein is a receptor for 
FGF or an FGF-binding protein incapable of FGF-mediated 
signal  transduction  is  not known.  However, its  properties 
suggest it may be an FGF receptor, and thus the 200-kD 
FGF-binding  protein  is  tentatively  identified  as  an  FGF 
receptor. Whether these  receptors are distinct proteins or 
whether one form is derived from the other is currently un- 
known. The apparent differential changes in levels of the two 
receptors during embryogenesis suggest they may represent 
independent polypeptides (see below). 
During chick development, 'zSI-aFGF binding is initially 
high and then decreases substantially. In the whole embryo, 
from day 2.5  to 7,  the level of '25I-aFGF binding remains 
relatively constant.  Specific binding first begins to decline 
around day 7 and is reduced 7--to  10-fold by day  13 (Figs. 
3 and 4). A survey of several tissues in which a biological 
role for FGF has been proposed revealed that day-19  em- 
bryos have low levels of FGF receptor in brain, liver, and eye 
and no detectable receptors in skeletal muscle or heart tissue 
(Fig.  3). The loss of the 200-kD receptor, which is nearly 
complete by day 9, occurs before the decline of the 150-kD 
receptor, which is still present at ~50% of its original level 
at day 9  (Fig. 4). 
A decrease in FGF receptor numbers appears to be the pri- 
mary cause for loss of '25I-aFGF  binding  sites since sub- 
stantial numbers of cryptic receptors retaining bound endog- 
enous  FGF  were  not  detected  after  acid  treatment  of 
membrane preparations. Membrane acidification results in 
1.4- to 2.0-fold increases in the number of high affinity bind- 
ing sites that is similar in samples with high (day 7) or low 
OIwin and Hauschka Fibroblast Growth Factor Receptor Regulation  507 (day  19)  numbers of receptors,  thus  implying that the de- 
crease in receptors is not an artifact of residual  FGF (Table 
I). Further evidence in support of this conclusion is derived 
from equilibrium binding studies.  The variation  in Kd de- 
termined by Scatchard  analyses of equilibrium binding data 
between  different  preparations  of day-7 chick  membranes 
using  different  ~25I-aFGF preparations  varies  from two- to 
threefold, suggesting the differences in affinities between day 
3.5, 7, and 13 are not significant. Within an individual experi- 
ment using a single  preparation of membranes  and ~I-aFGE 
the variation  in Kd was <l.5-fold.  Assuming  similar affini- 
ties of chick and bovine FGF, Scatchard  analysis of equilib- 
rium binding data from a range of developmental stages thus 
demonstrates insignificant changes in affinity of FGF recep- 
tor for ~25I-aFGF but substantial  decreases in FGF receptor 
number at older stages.  Data from cross-linking experiments 
demonstrating  a loss of FGF receptor polypeptides after day 
7  are in agreement with these results. 
Regulation of FGF receptor levels occurs during differen- 
tiation of skeletal  muscle cells (Olwin and Hauschka,  1988) 
and in murine embryonal carcinoma cell lines (Rizzino et al., 
1988).  Differentiation of skeletal muscle myoblasts,  which 
require  FGF  for growth  and  repression  of differentiation, 
results  in  a  permanent  loss  of FGF  receptor with a  time 
course  that  parallels  that  of  differentiation  (Olwin  and 
Hauschka,  I988).  Similar losses of FGF receptor occur in 
primary  chick skeletal  muscle cultures  (Olwin,  B.  B.,  un- 
published data). If muscle differentiation  in vivo is accompa- 
nied by FGF receptor loss, then day-9 and older embryonic 
skeletal muscle tissue should exhibit progressively  reduced 
levels of FGF  receptor as  increasing  proportions of myo- 
blasts become terminally differentiated.  Since skeletal mus- 
cle precursor cells account for most of the tissue mass in day- 
4.5-7 limbs and since FGF receptors are known to be present 
in primary  chick myoblasts  in vitro (Seed  and  Hauschka, 
1988; Olwin, B. B., unpublished data), the limb bud and also 
skeletal muscle data (Fig. 3 b) are consistent with the hypoth- 
esis that FGF receptors also disappear  as myoblasts  differen- 
tiate in vivo. These results  provide further evidence in sup- 
port  of a model,  previously proposed for cultured  skeletal 
muscle  cells,  in which expression  of FGF  receptor levels 
may function to control temporal FGF-dependent processes 
(Lim and Hauschka,  1984; Olwin and Hauschka,  1988).  Reg- 
ulation of FGF receptor levels within embryonic limb myo- 
genic  tissue  is  particularly  intriguing,  since  strong  im- 
munopositive  staining  for  FGF  also  occurs  in  the  same 
myogenic regions (Joseph-Siverstein et al.,  1989) and then, 
in adult muscle, becomes localized within the muscle base- 
ment lamina (DiMario et al.,  1989). 
Changes in FGF receptor levels during cellular differenti- 
ation in culture and during chick embryogenesis suggest that 
regulation of FGF receptor expression may play a key role 
in mediating the appropriate  temporal and spatial actions of 
FGF  during  development.  FGF-mediated  developmental 
events occur as early as the gastrula  stage in amphibian  em- 
bryos (Slack et al.,  1987;  Kimelman and Kirschner,  1987). 
FGF and transforming  growth factor ~, which potentiates  the 
inductive effect of FGF (Weeks and Melton,  1987;  Rosa et 
al.,  1988),  are  stored  in  unfertilized  amphibian  eggs  as 
mRNAs (Weeks and Melton,  1987;  Kimelman et al.,  1988) 
and in unfertilized chick eggs as FGF protein  (Seed et al., 
1988). It seems likely that the mechanisms regulating  meso- 
derm induction will entail not only the controlled temporal 
and spatial release of  FGF from the inducing endoderm cells 
but also the regulated expression of FGF receptors  in re- 
sponding cells. 
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